At present, there is an established clinical standard for treating joint disease: the total joint replacement. Yet, while the surgical devices and techniques used to implant them have been largely perfected, today’s standard replacement joints are very invasive, and not permanent. The lifespan of common replacement joints limits their effective use in patients aged 55 or older. This leaves patients between ages 18 and 55 suffering from cartilage damage, traumatic injury, or early stage cartilage loss with limited treatment options. Nanochon, is developing an implant designed to not only replace lost and damaged cartilage, but also to encourage new tissue growth. Using 3-D printing and a novel material, the Nanochon implant is a sturdy medical advancement that is both an orthopedic load bearing implant as well a tissue growth scaffold. The Nanochon implant has the potential to deliver faster and more successful recoveries for patients, while reducing costs to health providers, payers, and patients. Nanochon’s aim is to set a new clinical standard for cartilage restoration.
Location: United States
Employees: 1-10
Total raised: $10.1M
Founded date: 2016
Investors 5
| Date | Name | Website |
| - | CAV Angels | cavangels.... |
| - | MassChalle... | masschalle... |
| - | Wealthing ... | wealthing.... |
| 12.06.2021 | Creative D... | creativede... |
| - | K2X | k2x.capita... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 12.01.2026 | - | $4.1M | - |
| 07.05.2024 | Seed | $4M | - |
| 15.09.2021 | Seed | $2M | - |
Mentions in press and media 21
| Date | Title | Description |
| 14.01.2026 | Biotech Innovator bit.bio Secures $50M to Revolutionize Drug Discovery | bit.bio, a pioneering UK biotech, has secured $50 million in Series C funding, led by M&G Investments. This significant capital infusion will supercharge its human cell programming technology. The company aims to accelerate drug discove... |
| 13.01.2026 | Nanochon Secures $4.1M to Advance Knee Cartilage Implant | Nanochon, a Washington D.C. orthopedic company, has announced a successful $4.1 million Seed Prime II funding round. This investment elevates their total capital to $11.3 million. The new funds are earmarked for critical advancements. They ... |
| 12.01.2026 | bit.bio Raises $50M in Funding | bit.bio, a Cambridge, UK-based biotech company leveraging human cell programming technology, raised $50M in funding. The round was led by M&G Investments. The company intends to use the funds to accelerate the development of, and access... |
| 12.01.2026 | Nanochon Closes $4.1M Seed Prime II Funding Round | Nanochon, a Washington, D.C.-based orthopedic device company developing an implant for treating articular cartilage defects in the knee, raised 4.1m in Seed Prime II funding. The round, which brought total funding to $11.3m, was led by cult... |
| 12.01.2026 | Nanochon: $4.1 Million Seed Prime II Round Raised To Advance Knee Cartilage Implant Into First-in-Human Study | Nanochon, a Washington, D.C.-based orthopedic device company developing an implant to treat articular cartilage defects in the knee, said it has secured commitments to close an oversubscribed $4.1 million Seed Prime II financing, bringing t... |
| 17.07.2025 | Nanochon Receives Health Canada Approval to Launch First-in-Human Trial of 3D Printed Knee Implant | Health Canada, the federal regulatory authority, has approved U.S. medical device startup Nanochon’s clinical trial design, authorizing the launch of a first-in-human study for its 3D printed Chondrograft knee implant. The trial will assess... |
| 10.05.2024 | Nanochon's Groundbreaking Orthopedic Innovation Secures $4 Million in Funding | Nanochon, a cutting-edge orthopedic device biotech company based in Washington, DC, has recently closed a significant $4 million series seed prime fundraising round. Spearheaded by The University of Virginia Licensing and Ventures Group See... |
| 07.05.2024 | Nanochon: Orthopedic Device Biotech Company Secures $4 Million | Nanochon, a Washington, DC-based orthopedic device biotech company, announced it has raised $4 million in its series seed prime fundraising round. The funding round was led by The University of Virginia Licensing and Ventures Group Seed Fun... |
| 06.05.2024 | Nanochon Closes $4M Series Seed Prime | Nanochon, a Washington, DC-based orthopedic device biotech company, raised $4M in its series seed prime fundraising round. The round was led by The University of Virginia Licensing and Ventures Group Seed Fund, with participation from Culti... |
| 29.11.2023 | Nanochon Receives Investment From cultivate(MD) Capital Funds | Nanochon, a Washington, DC-based company provider of solutions for sports medicine physicians, received an investment from cultivate(MD) Capital Funds. The amount of the deal was not disclosed. The company intends to use the funds to expand... |